// App-Quantinova.ai

SAT0240 : THE LEVELS OF PLASMINOGEN AND PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1 IN ANTIPHOSPHOLIPID SYNDROME

Researchers

Presenter

  • T.M. Reshetnyak

Principal Investigators

  • E.V. Ostryakova

  • R.B. Aisina

  • L. Muhametova

  • D. Gulin

  • E.N. Alexandrova

  • A.V. Volkov

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

  • Antiphospholipid syndrome

  • Venous thrombosis

Biomarkers

  • Plasminogen activator ihnibitor-1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim